Here are the screening tests and immunizations that most women ages 40 to 49 need. This plan does not include recommendations for pregnancy. Although you and your healthcare provider may decide that a different schedule is best for you, this plan can guide your discussion.
Screening
|
Who needs it
|
How often
|
Type 2 diabetes or prediabetes
|
All adults beginning at age 45 and adults with no symptoms at any age who are overweight or obese and have 1 or more additional risk factors for diabetes
|
At least every 3 years
|
Alcohol misuse
|
All adults
|
At routine exams
|
Blood pressure
|
All adults
|
Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure recommends the following screening schedules:
|
Breast cancer
|
All women*
|
Screening with a mammogram every year is an option starting at age 40. At age 45 start yearly mammograms.*
|
Cervical cancer
|
All women, except those who had a hysterectomy (with removal of the cervix) for reasons not related to cervical cancer and no history of cervical cancer or serious precancer
|
Women between the ages of 30 and 65 should have a Pap test plus an HPV test (called "co-testing") every 5 years. This is the preferred approach, but it is also acceptable to continue to have Pap tests alone every 3 years.
|
Chlamydia
|
Women at increased risk for infection
|
At routine exams if at risk
|
Depression
|
All adults in clinical practices that have staff and systems in place to assure accurate diagnosis, effective treatment, and follow-up
|
At routine exams
|
Gonorrhea
|
Sexually active women at increased risk for infection
|
At routine exams if at risk
|
Hepatitis C
|
Anyone at increased risk; 1 time for those born between 1945 and 1965
|
At routine exams if at risk
|
HIV
|
All women
|
At routine exams
|
Lipid disorders
|
All women age 45 and older at increased risk for coronary artery disease
For women ages 19 to 44, screening should be based on risk factors1; discuss with your healthcare provider
|
At least every 5 years
|
Obesity
|
All adults
|
At routine checkups
|
Syphilis
|
Women at increased risk for infection
|
At routine exams if at risk
|
Tuberculosis
|
Anyone at increased risk for infection
|
Check with your healthcare provider
|
Vision
|
All adults2
|
Baseline comprehensive exam at age 40; if you have a chronic disease, check with your healthcare provider for exam frequency
|
Counseling
|
Who needs it
|
How often
|
Breast cancer, chemoprevention
|
Women at high risk
|
When risk is identified
|
BRCA mutation testing for breast and ovarian cancer susceptibility
|
Women with increased risk
|
When risk is identified
|
Diet and exercise
|
Adults who care overweight or obese
|
When diagnosed and at routine exams
|
Domestic violence
|
Women of child-bearing age
|
At routine exams
|
Sexually transmitted disease prevention
|
Anyone at increased risk for infection
|
At routine exams
|
Tobacco use and tobacco-related disease
|
All adults
|
Every exam
|
Immunization
|
Who needs it
|
How often
|
Tetanus/diphtheria/pertussis (Td/Tdap) booster
|
All adults
|
Td: every 10 years
Tdap: substitute a one-time dose of Tdap for a Td booster after age 18, then boost with Td every 10 years
|
Chickenpox (varicella)
|
All adults in this age group who have no record of previous infection or vaccinations
|
2 doses; the second dose should be given at least 4 weeks after the first dose
|
Measles, mumps, rubella (MMR)
|
All adults in this age group who have no record of previous infection or vaccinations
|
1 or 2 doses
|
Flu vaccine (seasonal)
|
All adults
|
Yearly, when the vaccine becomes available in the community
|
Hepatitis A vaccine
|
People at risk3
|
2 doses given 6 months apart
|
Hepatitis B vaccine
|
People at risk4
|
3 doses; the second dose should be given 1 month after the first dose; the third dose should be given at least 2 months after the second dose (and at least 4 months after the first dose)
|
Haemophilus influenzae type B (HIB)
|
People at risk
|
1 to 3 doses
|
Meningococcal
|
People at risk**
|
1 or 2 doses
|
Pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23)
|
People at risk5
|
1 or 2 doses
|